These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23540051)

  • 1. Framework for verifying elimination of measles and rubella.
    Wkly Epidemiol Rec; 2013 Mar; 88(9):89-99. PubMed ID: 23540051
    [No Abstract]   [Full Text] [Related]  

  • 2. Global measles and rubella laboratory network support for elimination goals, 2010–2015.
    Wkly Epidemiol Rec; 2016 May; 91(18):240-6. PubMed ID: 27156255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Elimination of measles and rubella in Germany: Progress and hindrances].
    Pfaff G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1222-4. PubMed ID: 23990082
    [No Abstract]   [Full Text] [Related]  

  • 4. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the current prevention strategy based on vaccination coverage and epidemiological surveillance sufficient to achieve measles and rubella elimination in Europe?
    Plans-Rubio P
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):723-6. PubMed ID: 24807016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.
    Papania MJ; Wallace GS; Rota PA; Icenogle JP; Fiebelkorn AP; Armstrong GL; Reef SE; Redd SB; Abernathy ES; Barskey AE; Hao L; McLean HQ; Rota JS; Bellini WJ; Seward JF
    JAMA Pediatr; 2014 Feb; 168(2):148-55. PubMed ID: 24311021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles and rubella eradication.
    Hinman AR
    Vaccine; 2018 Jan; 36(1):1-3. PubMed ID: 29183733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.
    Deblina Datta S; Tangermann RH; Reef S; William Schluter W; Adams A
    J Infect Dis; 2017 Jul; 216(suppl_1):S351-S354. PubMed ID: 28838172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roadmap to elimination standard measles and rubella surveillance.
    Wkly Epidemiol Rec; 2017 Mar; 92(9-10):97-105. PubMed ID: 28262010
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards rubella elimination in Japan.
    Jindai K; Funaki T; Nishijima T; Takakura S; Noda H; Miyake K
    Lancet Infect Dis; 2018 Jul; 18(7):713-714. PubMed ID: 29976516
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices.
    Castillo-Solorzano C; Marsigli C; Danovaro-Holliday MC; Ruiz-Matus C; Tambini G; Andrus JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S279-83. PubMed ID: 21666173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. India after polio.
    Burki T
    Lancet Infect Dis; 2014 Apr; 14(4):274-5. PubMed ID: 24800300
    [No Abstract]   [Full Text] [Related]  

  • 14. Global measles and rubella laboratory network--update.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Nov; 80(44):384-8. PubMed ID: 16300026
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):492-495. PubMed ID: 32091024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT; Lessler J; Metcalf CJ
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating measles and rubella surveillance: the experience in the Caribbean.
    Irons B; Carrasco P; Morris-Glasgow V; Castillo-Solórzano C; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S153-7. PubMed ID: 12721907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algoritmo diagnóstico para la confirmación de casos de sarampión y rubéola en México.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):532-536. PubMed ID: 31695226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.